ARTA
FLNA

A.R.T. Advisors’s Filana Therapeutics FLNA Stock Holding History

A.R.T. Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-24,043
Closed -$29K – 1668
2019
Q3 		$29K Buy
+24,043
New +$30.9K ﹤0.01% 1355
2018
Q4 		– Sell
-57,438
Closed -$58K – 1607
2018
Q3 		$58K Buy
+57,438
New +$87.3K ﹤0.01% 1312
2017
Q4 		– Sell
-10,796
Closed -$43K – 1632
2017
Q3 		$43K Sell
10,796
-14,159
-57% -$50.6K ﹤0.01% 1266
2017
Q2 		$102K Buy
24,955
+11,798
+90% +$55.7K 0.01% 1253
2017
Q1 		$82K Buy
13,157
+11,457
+674% +$52K ﹤0.01% 1289
2016
Q4 		$6K Buy
+1,700
New +$7.88K ﹤0.01% 1257
2016
Q3 		– Sell
-1,975
Closed -$30K – 1091
2016
Q2 		$30K Sell
1,975
-29
-1% -$460 ﹤0.01% 1288
2016
Q1 		$31K Sell
2,004
-2,157
-52% -$27.9K ﹤0.01% 1305
2015
Q4 		$50K Buy
4,161
+1,071
+35% +$14.2K ﹤0.01% 1383
2015
Q3 		$39K Buy
3,090
+400
+15% +$5.05K ﹤0.01% 1302
2015
Q2 		$32K Buy
+2,690
New +$36.9K ﹤0.01% 1421
2014
Q3 		– Sell
-4,205
Closed -$169K – 1500
2014
Q2 		$169K Sell
4,205
-295
-7% -$10.9K 0.01% 1165
2014
Q1 		$173K Buy
+4,500
New +$159K 0.01% 1169

Other funds holding FLNA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

A.R.T. Advisors's FLNA Position: Q4 2019 in Review

A.R.T. Advisors sold out of Filana Therapeutics (FLNA) in Q4 2019, closing a stake of 24,043 shares — an estimated $29K sold.

A.R.T. Advisors first reported a position in FLNA in Q1 2014 and held it in 13 quarters. The position peaked at $173K in Q1 2014. 31 funds tracked by Wall St. Rank hold FLNA as of Q4 2019.

  • A.R.T. Advisors reported no remaining Filana Therapeutics position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 24,043 Filana Therapeutics shares in Q4 2019, an estimated $29K.
  • A.R.T. Advisors first reported a position in Filana Therapeutics in Q1 2014 and held it in 13 quarters.
  • A.R.T. Advisors's Filana Therapeutics position peaked at $173K in Q1 2014.
  • 31 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.